Survival analysis showed that high PPRC1 expression in six tumors, including Adrenocortical carcinoma (ACC), Bladder Urothelial Carcinoma (BLCA), Kidney renal papillary cell carcinoma (KIRP), Liver hepatocellular carcinoma (LIHC), Ovarian serous cystadenocarcinoma (OV), and Skin Cutaneous Melanoma(SKCM), was associated with poorer OS (Figure 2A–F). Here, PPRC1 is linked to ovarian serous cystadenocarcinoma.